After expert review organized by the Innovative Medical Device Review Office of the Medical Device Technical Evaluation Center of the National Medical Products Administration (NMPA), the Pulsed Field Ablation Therapeutic Apparatus independently developed by Tianjin Intelligent Health Co.,Ltd, a wholly-owned subsidiary of Shanghai Yuanshan Medical Technology Co., Ltd. (referred to as "Alpemd"), has been approved to enter the special review program for innovative medical devices on February 22, 2022. This is the second innovative product of Alpmed to enter the special approval program after the High Voltage Steep Pulse Minimally Invasive Therapeutic system, and also the first domestically produced PFA product approved for innovative medical devices.